Collectively, these results indicate that lnc-CRAT40 acts as a scaffold to recruit YBX1 to the RelA promoter, promoting RelA transcription, activating NF-κB signaling, and driving CRC progression. This evidence concerns the gene NFKB1 and colorectal carcinoma.